Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Sjogren s syndrome.php on line 2
Sjogren s syndrome
LE WE PMID CA
Sjogren s syndrome2552Sjoegren Syndrom

Autoantibodies Anti AChR M3

Eye and Orbita (Xerophthalmia)

Immunoglobulin G4 spectrum disorder

Mikulicz s disease

NOD mouse

Pulmonary nodular lymphoid hyperplasia

Sjogren s syndrome

1986  
1
Clinical aspects of Sjögren's syndrome.
[3014664] South Med J 79(7): 857-62 (1986)
2004  
2
Clinical manifestations and early diagnosis of Sjögren syndrome.
[15226160] Arch Intern Med 164(12): 1275-84 (2004)
2003  
3
2005  
4
Primary Sjögren's syndrome: new clinical and therapeutic concepts.
[15498797] Ann Rheum Dis 64(3): 347-54 (2005)
2002  
5
Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.
[12006334] Ann Rheum Dis 61(6): 554-8 (2002)
1999  
6
Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome.
[10419864] Ann Rheum Dis 58(8): 465-74 (1999)
2007  
7
B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue.
[17697366] Arthritis Res Ther 9(4): 218 (2007)
2001  
8
The management of Sjögren's syndrome in dental practice.
[11680356] J Am Dent Assoc 132(10): 1409-17; quiz 1460-1 (2001)
1998  
9
Sjögren's syndrome: a model for dental care in the 21st century.
[9631612] J Am Dent Assoc 129(6): 719-28 (1998)
2004  
10
Altered autoantigen structure in Sjögren's syndrome: implications for the pathogenesis of autoimmune tissue damage.
[15187033] Crit Rev Oral Biol Med 15(3): 156-64 (2004)
2002  
11
Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update.
[12097234] Crit Rev Oral Biol Med 13(1): 5-16 (2002)
2001  
12
Pathogenetic factors in Sjögren's syndrome: recent developments.
[11497375] Crit Rev Oral Biol Med 12(3): 244-51 (2001)
1996  
13
Current concepts of autoimmune exocrinopathy: immunologic mechanisms in the salivary pathology of Sjögren's syndrome.
[8875029] Crit Rev Oral Biol Med 7(2): 144-58 (1996)
2001  
14
A review and update of Sjögren's syndrome: manifestations, diagnosis, and treatment.
[11605978] Am J Manag Care 7(14 Suppl): S433-43 (2001)
2005  
15
Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going?
[16200578] Arthritis Rheum 52(10): 2984-95 (2005)
1960  
16
The pathology of Mikulicz-Sjogren disease in relation to disseminated lupus erythematosus. A review of the autopsy findings and presentation of a case.
[13795891] Can Med Assoc J 82(-): 143-8 (1960)
1976  
17
Pulmonary manifestations of Sjogren's syndrome.
[989035] Chest 70(03): 354-61 (1976)
2007  
18
Emerging biological therapies in primary Sjogren's syndrome.
[17586555] Rheumatology (Oxford) 46(9): 1389-96 (2007)
2006  
19
Sjogrens syndrome--the non-apoptotic model of glandular hypofunction.
[16595520] Rheumatology (Oxford) 45(7): 792-8 (2006)
2005  
20
Primary Sjögren's syndrome: current and emergent aetiopathogenic concepts.
[15956090] Rheumatology (Oxford) 44(11): 1354-67 (2005)
1975  
21
Medical Staff Conference: Recent clinical and experimental developments in Sjögren's syndrome.
[1109526] West J Med 122(1): 50-8 (1975)
2010  
22
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome.
[19561361] Ann Rheum Dis 69(6): 1103-9 (2010)
2003  
23
Parasympathetic nervous system dysfunction in primary Sjögren's syndrome.
[12860722] Ann Rheum Dis 62(8): 702-4 (2003)
2011  
24
Current concepts: mouse models of Sjögren's syndrome.
[21253584] J Biomed Biotechnol 2011(-): 549107 (2011)
2008  
25
Expression and function of ETA and ETB receptors in SSc.
[18784135] Rheumatology (Oxford) 47 Suppl 5(-): v27-8 (2008)
2008  
26
Prevention of congenital heart block in children of SSA-positive mothers.
[18504284] Rheumatology (Oxford) 47 Suppl 3(-): iii35-7 (2008)
2009  
27
Sjögren's syndrome of the oral cavity. Review and update.
[19300364] Med Oral Patol Oral Cir Bucal 14(7): E325-30 (2009)
2010  
28
Treatment of primary Sjögren syndrome: a systematic review.
[20664046] JAMA 304(4): 452-60 (2010)
2010  
29
Role of immune response to M3 muscarinic acethylcholine receptor in the pathogenesis of Sjögren's syndrome.
[20453444] Nihon Rinsho Meneki Gakkai Kaishi 33(2): 87-91 (2010)
2007  
30
Pulmonary nodular lymphoid hyperplasia associated with Sjögren's syndrome.
[17939337] Korean J Intern Med 22(3): 192-6 (2007)
2006  
31
A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease.
[17164992] Mod Rheumatol 16(6): 335-40 (2006)
2007  
32
The future of biologic agents in the treatment of Sjögren's syndrome.
[17992596] Clin Rev Allergy Immunol 32(3): 292-7 (2007)
2009  
33
Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease.
[19214349] Ocul Surf 7(1): 11-27 (2009)
2006  
34
A new approach to managing oral manifestations of Sjogren's syndrome and skin manifestations of lupus.
[16756750] J Biochem Mol Biol 39(3): 229-39 (2006)
PMC   
35
Pulmonary Arterial Hypertension in Patients with Primary Sjogren's Syndrome.
[24511390] Autoimmune Dis 2014():710401 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Sjogren s syndrome.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Sjogren s syndrome.php on line 92